Artelo Biosciences, Inc. (ARTL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.1
Day's range
$1.31

Artelo Biosciences Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANE STREET GROUP, LLC 08/14/2026 66.34 K $74.30 K   407.23% 2.45%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 13.86 K $15.53 K   100.00% 0.51%
STONEX GROUP INC. 08/12/2026 12.40 K $14.69 K   100.00% 0.46%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 10.13 K $11.34 K   0.00% 0.37%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 8.44 K $9.45 K   198.48% 0.31%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 3.14 K $3.52 K   0.00% 0.12%
UBS GROUP AG 08/13/2026 2.80 K $3.14 K   100.00% 0.10%
ROTHSCHILD INVESTMENT LLC 08/06/2026 2 $2   0.00% 0.00%
TD WATERHOUSE CANADA INC. 07/27/2026 2 $2   100.00% 0.00%
DANSKE BANK A/S 08/10/2026 1 $1   100.00% 0.00%
CITIGROUP INC 08/03/2026 0 $0   -100.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 0 $0   -100.00% 0.00%
KATHMERE CAPITAL MANAGEMENT, LLC 07/29/2026 0 $0   -100.00% 0.00%
CLEAR STREET GROUP INC. 08/12/2026 0 $0   -100.00% 0.00%

Artelo Biosciences Inc institutional Ownership - FAQ's

During the previous two years, 17 institutional investors and hedge funds held shares of Artelo Biosciences Inc. The most heavily invested institutionals were:

JANE STREET GROUP, LLC: 66,341

GEODE CAPITAL MANAGEMENT, LLC: 13,864

StoneX Group Inc.: 12,400

VANGUARD CAPITAL MANAGEMENT LLC: 10,129

Tower Research Capital LLC (TRC): 8,435

VANGUARD FIDUCIARY TRUST CO: 3,139

4.32% of Artelo Biosciences Inc stock is owned by institutional investors.

Institutional investors have bought a total of 146.15 K shares in the last 24 months. This purchase volume represents approximately $170.99 K in transactions.